Back
Savara Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
59
SVRA
Savara
Last Price:
4.38
Seasonality Move:
8.35%
Buy
53
NBY
NovaBay Pharmaceuticals
Last Price:
0.14
Seasonality Move:
-0.33%
Buy
59
Savara (SVRA)
is a Buy
Is Savara a Buy, Sell or Hold?
- The current Savara [SVRA] share price is $4.30. The Score for SVRA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- SVRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
NovaBay Pharmaceuticals (NBY)
is a Buy
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.13. The Score for NBY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- NBY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight selling pressure.
SVRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 41.39 | Sell |
| Chaikin Money Flow: | 478063 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.44 - 4.96) | Sell |
| Bollinger Bands (100): | (4.5 - 5.1) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 59.53 | Buy |
| Chaikin Money Flow: | -4866464 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.07 - 0.11) | Buy |
| Bollinger Bands (100): | (0.09 - 0.17) | Buy |
SVRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.57 | Sell |
| 20-day SMA: | 4.67 | Sell |
| 50-day SMA: | 4.78 | Sell |
| 200-day SMA: | 4.29 | Buy |
| 8-day EMA: | 4.53 | Sell |
| 20-day EMA: | 4.67 | Sell |
| 50-day EMA: | 4.75 | Sell |
| 200-day EMA: | 4.25 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.11 | Buy |
| 20-day SMA: | 0.1 | Buy |
| 50-day SMA: | 0.1 | Buy |
| 200-day SMA: | 0.28 | Sell |
| 8-day EMA: | 0.12 | Buy |
| 20-day EMA: | 0.1 | Buy |
| 50-day EMA: | 0.11 | Buy |
| 200-day EMA: | 0.49 | Sell |
Savara Earnings Growth & SVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Savara Technical Analysis
| May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||